Metraipolis › archive › dc_17dc9816702d
Dupilumab efficacy by disease severity in pediatric type 2 asthma — Europe PMC PMID:41200848
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41200848
- DOI
- 10.1111/pai.70196
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T20:49:58.660Z
- SHA-256 of the archived text
6b6c641b00f29d13b5e8f42801889af906ac19f2c68e91f354de1a316850b9ea- Stable URL of this page
https://metraipolis.com/documento/dc_17dc9816702d
How to cite
Dupilumab efficacy by disease severity in pediatric type 2 asthma — Europe PMC PMID:41200848 — Europe PMC (en), https://europepmc.org/article/MED/41200848 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_17dc9816702d (Metraipolis archive dc_17dc9816702d, sha256 6b6c641b00f29d13b5e8f42801889af906ac19f2c68e91f354de1a316850b9ea)
BibTeX
@misc{dc17dc9816702d,
title = {Dupilumab efficacy by disease severity in pediatric type 2 asthma — Europe PMC PMID:41200848},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41200848},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_17dc9816702d; sha256 6b6c641b00f29d13b5e8f42801889af906ac19f2c68e91f354de1a316850b9ea},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41200848. Agents can read the archived copy with the MCP tool read_document.